In the era of DOACs, risk for CTEPH following pulmonary embolism is affected by multiple factors, including gender and heart load.
慢性血栓栓塞性肺动脉高压(CTEPH)属于第四大类肺动脉高压。由于CTEPH的症状缺乏特异性,早期识别和诊断仍面临重大挑战。近年来,随着手术、介入技术的广泛开展以及靶向治疗药物的应用,CTEPH患者的预后显著改善。11月22日至24日,北京大学人民医 ...
为梳理 2024 年慢阻肺病领域的重要研究进展,聚焦最前沿的诊疗经验,丁香园和中国医科大学附属第一医院呼吸与危重症医学科联合举办了「2024 ...
Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) were severe, progressive diseases that impaired physical functioning, with the 6-minute walk test (6MWT) ...
慢性肺栓塞——这一致命病症,往往在暗中威胁着无数人。其主要成因是肺动脉及其分支中的血栓反复或持续堵塞,最终导致血栓的机化和肺循环障碍,形成慢性血栓栓塞性肺动脉高压(CTEPH)。这一病症不仅使得患者的呼吸变得困难,甚至可能在不知不觉中引发右心衰竭,严重影响生活质量。肺动脉内膜剥脱术正是针对CTEPH的根治手段,但由于其高难度性,目前仍在许多医疗机构难以实施。 在中日友好医院,肺血管病团队不仅成功完 ...
慢性肺栓塞是一种由肺动脉及其分支血栓形成引发的复杂病症,长时间存在的血栓会导致肺循环障碍和肺动脉压力升高,最终可能引发右心衰竭。这种情况被称为慢性血栓栓塞性肺动脉高压(CTEPH),目前唯一的根治性治疗手段就是肺动脉内膜剥脱术。然而,手术的复杂性和需要在停循环状态下完成的特性,给医生带来了巨大的挑战。最近,中日友好医院的肺血管病团队成功实施了一例高难度的CTEPH肺动脉内膜剥脱术,标志着该团队完成 ...
PAH is a rare condition in children, but is often fatal if left untreated, and protocols for pediatric patients have not been ...
慢性肺栓塞主要是由肺动脉及其分支反复或持续出现血栓栓塞,血栓不能完全溶解并逐渐机化所导致的一组肺循环障碍临床 ...
The EMA approved Adempas four months after Opsumit but for two indications- PAH and chronic thrombo-embolic pulmonary hypertension (CTEPH). However, the EMA estimated only a minor increase in the ...
Methods All patients with idiopathic or heritable PAH diagnosed in 1995–2008 were identified. Controls were selected from patients with chronic thromboembolic pulmonary hypertension (CTEPH). Full ...
In order to obtain a wide range of perspectives on living with PH, we aimed to include patients with PAH or CTEPH of varying severities, from several different countries and with a wide range of ...